DRUG STUDY

Name: De la Cruz, Jose Date Admitted: October 9, 2020

Age: 55 yrs old Ward: Surgical Ward
Address: Loon, Bohol Admitting Diagnosis: Acute Appendicitis
Religion: Roman Catholic Attending Physician: Dr. Macapunit
Name Of Dosage/ Rout e Classificatio Mechanism Of Action Indication Contraindication Nursing
Drugs Frequenc y n Responsibilities

Ceftriaxone 1g IVTT Antibiotics Ceftriaxone is used for theCeftriaxone is used for the Hypersensitive to • Nurse should advise
treatment of the infections treatment of the infections cephalosporins, penicillins the patient to
(respiratory, skin, soft tissue, (respiratory, skin, soft tissue, UTI, andrelatedantibiotics. promptly report
UTI, ENT) caused by susceptible sign of adverse
ENT) caused by susceptible organisms. Organisms that are reaction
organisms.11 Organisms that generally susceptible to ceftriaxone • Nurse should
are generally susceptible to include S. pneumoniae, S. pyogenes instruct patient to
ceftriaxone include S. (group A beta-hemolytic report pain
pneumoniae, streptococci), coagulase-negative • Nurse should advise
S. pyogenes (group A staphylococci, Some Enterobacter patient to report
betahemolytic streptococci), spp, H. influenzae, N. gonorrhoeae, immediately when
coagulasenegative P. mirabilis, E. coli, Klebsiella spp, loose stool or
staphylococci, Some M. catarrhalis, B. burgdorferi, and diarrhea occurs
Enterobacter spp, H. some oral anaerobes.
influenzae, N. gonorrhoeae, P.
mirabilis, E. coli, Klebsiella
spp, M. catarrhalis, B.
burgdorferi, and some oral
anaerobes.1
Ranitidine 50 g IVTT Histamine H2 After a meal, the hormone This drug is used alone or with Ranitidine is contraindicated Before
Antagonists gastrin, produced by cells in concomitant antacids for the for patients known to have • Assess patient for
the lining of the stomach, following conditions: short-term hypersensitivity to the drug or epigastric or
stimulates the release of treatment of active duodenal ulcer, any of the ingredients abdominal pain and
histamine, which then binds to treating gastric acid hypersecretion Acute polyuria, treatment frank or occult
histamine H2 receptors, due to Zollinger-Ellison syndrome, with ranidine may mask the blood in the stool,
leading to the secretion of systemic mastocytosis, and other symptoms of other gastric emesis, or gastric
gastric acid. Ranitidine conditions that may pathologically disease, raised liver enzyme aspirate
reduces the secretion of raise gastric acid levels. It also used may occur with high doses. • Assess geriatric and
gastric acid by reversible in the short term treatment of debilitated patients
binding to histamine (H2) active benign gastric ulcers and routinely for
receptors, which are found on maintenance therapy of gastric confusion. report
gastric parietal cells. This ulcers at a reduced dose. In promptly
process leads to the inhibition addition to the above, ranitidine During
of histamine binding to this can be used for the treatment of • Administer over at
receptor, causing the GERD symptoms, treatment of least 5 mins. Rapid
reduction of gastric acid erosive administration may
secretion. The relief of gastric-
acid related symptoms can
occur as

soon as 60 minutes after esophagitis (endoscopically cause hypotension

administration of a single dose, diagnosed) and the maintenance of and arrhythmias.
and the effects can last from 4-10 gastric or duodenal ulcer healing. After
hours, providing fast and effective • Ranitidine may cause
symptomatic relief. false positive results
for urine protein: test
with sulfos alicylic
scid
• Administer with
meals or immediately
afterward and at
bedtime to prolong
effect